Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,729 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $574.10 | 10 | $0 (2024) |
| Intuity Medical Inc | $264.00 | 2 | $0 (2023) |
| Abbott Laboratories | $250.01 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $168.53 | 7 | $0 (2018) |
| Horizon Therapeutics plc | $124.99 | 1 | $0 (2019) |
| Optinose US, Inc. | $121.53 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $100.56 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.72 | 2 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $26.40 | 1 | $0 (2024) |
| Novo Nordisk Inc | $25.74 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.14 | 4 | AstraZeneca Pharmaceuticals LP ($250.00) |
| 2023 | $393.15 | 3 | Abbott Laboratories ($250.01) |
| 2022 | $149.58 | 3 | Intuity Medical Inc ($120.86) |
| 2021 | $121.53 | 1 | Optinose US, Inc. ($121.53) |
| 2019 | $279.04 | 4 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2018 | $232.74 | 9 | AstraZeneca Pharmaceuticals LP ($199.10) |
| 2017 | $251.05 | 7 | SANOFI-AVENTIS U.S. LLC ($134.89) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $143.14 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES CARE | ||||||
| 02/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Diabetes Care | ||||||
| 10/12/2022 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $120.86 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Gastroenterology | ||||||
| 04/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 10/27/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $121.53 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/04/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: RAYOS | ||||||
| 08/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2019 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: DIABETES | ||||||
| 10/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: DIABETES | ||||||
| 08/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $109.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 08/03/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $100.56 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 665 | 7,102 | $539,902 | $223,619 |
| 2022 | 11 | 1,251 | 9,215 | $628,868 | $271,247 |
| 2021 | 11 | 666 | 1,295 | $111,707 | $48,579 |
| 2020 | 9 | 225 | 530 | $45,365 | $19,336 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 292 | 4,875 | $445,510 | $168,773 | 37.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 206 | 1,830 | $60,519 | $38,456 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 184 | $24,032 | $13,408 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 26 | $1,950 | $1,369 | 70.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 24 | 25 | $1,537 | $580.05 | 37.7% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 19 | 40 | $1,934 | $553.99 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 35 | $716.12 | $294.00 | 41.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $553.46 | $178.61 | 32.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 70 | $3,150 | $6.87 | 0.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 489 | 4,317 | $431,700 | $150,769 | 34.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 572 | 4,448 | $149,514 | $93,875 | 62.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 270 | $34,125 | $21,685 | 63.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 12 | 13 | $4,628 | $2,471 | 53.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 16 | $1,984 | $1,082 | 54.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 12 | $780.00 | $426.24 | 54.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 17 | $1,037 | $396.93 | 38.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 11 | 12 | $1,200 | $240.68 | 20.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $450.00 | $197.21 | 43.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 33 | $660.00 | $97.92 | 14.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 62 | $2,790 | $5.74 | 0.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 247 | $30,875 | $19,402 | 62.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 181 | 334 | $33,400 | $11,800 | 35.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 123 | 182 | $24,860 | $9,207 | 37.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 143 | 199 | $6,736 | $4,321 | 64.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 39 | 53 | $3,975 | $2,719 | 68.4% |
About Dr. David Carmili, M.D
Dr. David Carmili, M.D is a Pediatrics healthcare provider based in Ridgewood, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497856942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Carmili, M.D has received a total of $1,729 in payments from pharmaceutical and medical device companies, with $302.14 received in 2024. These payments were reported across 31 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,729).
As a Medicare-enrolled provider, Carmili has provided services to 2,807 Medicare beneficiaries, totaling 18,142 services with total Medicare billing of $562,781. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Ridgewood, NY
- Active Since 09/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497856942
Products in Payments
- FARXIGA (Drug) $449.10
- Pogo Automatic Blood Glucose Monitoring System (Device) $264.00
- FREESTYLE LIBRE 3 (Device) $250.01
- AIRSUPRA (Drug) $125.00
- RAYOS (Drug) $124.99
- Xhance (Drug) $121.53
- SOLIQUA (Drug) $111.46
- JANUVIA (Drug) $100.56
- TOUJEO (Drug) $57.07
- XIFAXAN (Drug) $28.72
- ZORYVE (Drug) $26.40
- Ozempic (Drug) $25.74
- BREATHTEK (Device) $16.25
- NIOX VERO DEVICE (Device) $15.60
- JARDIANCE (Drug) $12.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Ridgewood
Dr. Jesus Pichardo, M.d, M.D
Pediatrics — Payments: $2,204
Dr. Sherry Singh, M.d, M.D
Pediatrics — Payments: $1,695
Dr. Frances Tubens, M.d, M.D
Pediatrics — Payments: $1,317
Dr. Fanny Garrido-Valencia, M.d, M.D
Pediatrics — Payments: $1,273
Iwona Mienko, Md, MD
Pediatrics — Payments: $964.64
Jonathan Florez
Pediatrics — Payments: $913.46